Dexlansoprazole

🧮 Dose calculator

Erosive esophagitis (GERD) · Regimen source: FDA Dexilant · 2.1, Table 1

• • Without regard to food; swallow whole. Moderate hepatic impairment: 30 mg up to 8 weeks; severe not recommended. FDA Dexilant · 2FDA Dexilant · 2.2

Enter age (weight is optional for this regimen).

👥 Special populations

• 🤰 PregnancyUse with caution

  Label states no clear risk or has limited data; use only if needed, under medical advice. FDA Dexilant · 8.1

  “Risk Summary There are no studies with dexlansoprazole use in pregnant women to inform a drug-associated risk.”

• 🤱 BreastfeedingUse with caution

  Label: use with caution while breastfeeding; see the label text. FDA Dexilant · 8.2

  “Risk Summary There is no information regarding the presence of dexlansoprazole in human milk, the effects on the breastfed infant, or the effects on milk production.”

• 👶 ChildrenUse with caution

  The label has conditions, age limits or notes for children; the label sentence is quoted below. FDA Dexilant · 8.4

  “The safety and effectiveness of DEXILANT have been established in pediatric patients 12 years to 17 years of age for the healing of all grades of EE, the maintenance of healed EE and relief of heartburn, and treatment of heartburn associated with symptomatic non-erosive GERD.”

• 👴 Older adultsUse with caution

  Label: use with caution in older adults, usually starting at the low end of the dose range. FDA Dexilant · 8.5

  “Of the total number of patients (n=4,548) in clinical studies of DEXILANT, 11% of patients were aged 65 years and over, while 2% were 75 years and over.”

• ⚥ Females & males of reproductive potentialNo data

  The source for this drug has no section for this group.